Cargando…

Signal Transducer and Activator of Transcription-3 Modulation of Cardiac Pathology in Chronic Chagasic Cardiomyopathy

Chronic Chagasic cardiomyopathy (CCC) is a severe clinical manifestation that develops in 30%–40% of individuals chronically infected with the protozoal parasite Trypanosoma cruzi and is thus an important public health problem. Parasite persistence during chronic infection drives pathologic changes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoffman, Kristyn A., Villar, Maria Jose, Poveda, Cristina, Bottazzi, Maria Elena, Hotez, Peter J., Tweardy, David J., Jones, Kathryn M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421853/ https://www.ncbi.nlm.nih.gov/pubmed/34504808 http://dx.doi.org/10.3389/fcimb.2021.708325

Ejemplares similares

Improved Biomarker and Imaging Analysis for Characterizing Progressive Cardiac Fibrosis in a Mouse Model of Chronic Chagasic Cardiomyopathy
por: Hoffman, Kristyn A., et al.
Publicado: (2019)

Echocardiographic Measurements in a Preclinical Model of Chronic Chagasic Cardiomyopathy in Dogs: Validation and Reproducibility
por: Carvalho, Eduardo B., et al.
Publicado: (2019)

Enhanced Migratory Capacity of T Lymphocytes in Severe Chagasic Patients Is Correlated With VLA-4 and TNF-α Expression
por: Berbert, Luiz Ricardo, et al.
Publicado: (2021)

Vaccine-linked chemotherapy improves cardiac structure and function in a mouse model of chronic Chagas disease
por: Jones, Kathryn M., et al.
Publicado: (2023)

Advancing a Human Onchocerciasis Vaccine From Antigen Discovery to Efficacy Studies Against Natural Infection of Cattle With Onchocerca ochengi
por: Zhan, Bin, et al.
Publicado: (2022)

Stroke Correlates in Chagasic and Non-Chagasic Cardiomyopathies
por: da Matta, José Alberto Martins, et al.
Publicado: (2012)

Analysis of Iron Metabolism in Chronic Chagasic Cardiomyopathy
por: Miranda, Carla Paixão, et al.
Publicado: (2019)

Left Atrial Function in Patients with Chronic Chagasic Cardiomyopathy
por: Fragata, Claudia da Silva, et al.
Publicado: (2015)

Air Pollution’s Impact on Cardiac Remodeling in an Experimental Model of Chagas Cardiomyopathy
por: Fonseca, Keila Cardoso Barbosa, et al.
Publicado: (2022)

Stem Cell-Based Therapies in Chagasic Cardiomyopathy
por: Campos de Carvalho, Antonio Carlos, et al.
Publicado: (2015)

Chemotherapeutic Efficacy of Phosphodiesterase Inhibitors in Chagasic Cardiomyopathy
por: Wen, Jian-jun, et al.
Publicado: (2016)

Chagasic Cardiomyopathy in Immigrants from Latin America to Spain
por: Pérez de Ayala, Ana, et al.
Publicado: (2009)

Cardiac condition in young chagasic women
por: Lassen, O, et al.
Publicado: (2013)

Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy
por: Muratore, Claudio A, et al.
Publicado: (2010)

Clinical and Echocardiographic Predictors of Mortality in Chagasic Cardiomyopathy - Systematic Review
por: Pereira, Clodoval de Barros, et al.
Publicado: (2014)

The metabogenic role of iron in chronic chagasic cardiac failure
por: Miranda, Carla Paixão, et al.
Publicado: (2015)

Chagas Cardiomyopathy Manifestations and Trypanosoma cruzi Genotypes Circulating in Chronic Chagasic Patients
por: Ramírez, Juan David, et al.
Publicado: (2010)

A protocol update for the Selenium Treatment and Chagasic Cardiomyopathy (STCC) trial
por: Holanda, Marcelo Teixeira, et al.
Publicado: (2018)

Role of FAK signaling in chagasic cardiac hypertrophy
por: Tucci, Amanda R., et al.
Publicado: (2020)

Repeat-Driven Generation of Antigenic Diversity in a Major Human Pathogen, Trypanosoma cruzi
por: Talavera-López, Carlos, et al.
Publicado: (2021)

Therapy with Cardiomyocytes Derived from Pluripotent Cells in Chronic Chagasic Cardiomyopathy
por: Brasil, Guilherme Visconde, et al.
Publicado: (2020)

Cardiovascular Magnetic Resonance Imaging Evidence of Edema in Chronic Chagasic Cardiomyopathy
por: Diaz, Andrés, et al.
Publicado: (2019)

Chagasic cardiomyopathy is marked by a unique signature of activated CD4(+) T cells
por: Almeida, Gregório Guilherme, et al.
Publicado: (2022)

Distinct Microbial Communities in Dilated Cardiomyopathy Explanted Hearts Are Associated With Different Myocardial Rejection Outcomes
por: Pereira, Jaqueline de Jesus, et al.
Publicado: (2021)

Circulating MicroRNAs and myocardial involvement severity in chronic Chagas cardiomyopathy
por: Gómez-Ochoa, Sergio Alejandro, et al.
Publicado: (2022)

Evaluation of VDR gene polymorphisms in Trypanosoma cruzi infection and chronic Chagasic cardiomyopathy
por: Leon Rodriguez, Daniel A, et al.
Publicado: (2016)

Translating Chagasic dilating cardiomyopathy to surgical therapies: An under published global challenge
por: Groom, Zoe C, et al.
Publicado: (2019)

Innate immune receptors over expression correlate with chronic chagasic cardiomyopathy and digestive damage in patients
por: Pereira, Nathalie de Sena, et al.
Publicado: (2018)

Trypanosoma cruzi vaccine candidate antigens Tc24 and TSA-1 recall memory immune response associated with HLA-A and -B supertypes in Chagasic chronic patients from Mexico
por: Villanueva-Lizama, Liliana E., et al.
Publicado: (2018)

Transcriptional regulation and drug resistance in Mycobacterium tuberculosis
por: Miotto, Paolo, et al.
Publicado: (2022)

Trypanosoma cruzi-specific CD8(+) T cells and other immunological hallmarks in chronic Chagas cardiomyopathy: Two decades of research
por: Puerta, Concepción J., et al.
Publicado: (2023)

Immunomodulation for the Treatment of Chronic Chagas Disease Cardiomyopathy: A New Approach to an Old Enemy
por: Santos, Emanuelle de Souza, et al.
Publicado: (2021)

Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection
por: Cruz-Chan, Julio V., et al.
Publicado: (2021)

Identification and Validation of Immune-Related Biomarker Gene and Construction of ceRNA Networks in Septic Cardiomyopathy
por: Li, Jingru, et al.
Publicado: (2022)

Transcriptional Studies on Trypanosoma cruzi – Host Cell Interactions: A Complex Puzzle of Variables
por: Libisch, María Gabriela, et al.
Publicado: (2021)

Verotoxin Receptor-Based Pathology and Therapies
por: Lingwood, Clifford
Publicado: (2020)

Trypanosoma cruzi P21: a potential novel target for chagasic cardiomyopathy therapy
por: Teixeira, Thaise Lara, et al.
Publicado: (2015)

Treatment With Suboptimal Dose of Benznidazole Mitigates Immune Response Molecular Pathways in Mice With Chronic Chagas Cardiomyopathy
por: Farani, Priscila Silva Grijó, et al.
Publicado: (2021)

A Wor1-Like Transcription Factor Is Essential for Virulence of Cryptococcus neoformans
por: Paes, Hugo Costa, et al.
Publicado: (2018)

Transcriptional Circuits Regulating Developmental Processes in Candida albicans
por: Rodriguez, Diana L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fvo5ef9bkloiqtsn3p0s34i1a4